Earth Science Tech, Inc. (ETST) Shares Progress on
Post# of 333
(Total Views: 217)
Posted On: 07/19/2018 4:59:05 PM
Earth Science Tech, Inc. (ETST) Shares Progress on CBD Formulas
- Continued progress on CBD patent formulas
- Update on the development of three CBD formulas already under the provisory patent
- Additional three products at various stages with Bionatus
Earth Science Tech, Inc. (OTC: ETST), a biotechnology company focused on cannabidiol (CBD), nutraceuticals, pharmaceuticals and medical devices, shared progress on its CBD patent formulas in a recent press release (http://nnw.fm/O6QyQ). The company has three new CBD formulas under the provisory patent and three Bionatus products in various stages of development.
ETST is developing three CBD formulas already under the provisory patent whose function is to maintain quality of life and prevent inflammation, cancer and degenerative diseases. The company announced in March (http://nnw.fm/QOd0b) that it had received a grant from the Government of Quebec earmarked for the pre-launch process of these three CBD-based nutraceutical provisional patent products.
Research and development has been very promising on the first two unique CBD formula products, a neuron protector and a breast protector. The final formulation is currently being developed to assure the longest possible shelf life using a yet to be determined natural protective agent. The third CBD formula is a unique superfood formulated from a mix of hemp oil and other vegetal oil(s), enriched with potent antioxidants and designed to improve antioxidant ingestion.
ETST has two products in development, Propovit and a reformulation of Bionatus, through a joint venture with Bionatus Laboratrio Botnico of Brazil and its Canadian division, Bionatus Botanical Laboratories, Inc. Propovit is used to help alleviate throat irritation, colds and bad breath. The new formulation will be enriched with ETST hemp oil. The main natural ingredient in Bionatus is the Guaco extract. Traditional uses of this extract suppose anti-inflammatory and bronchial-dilation properties, properties that ETST and Bionatus believe will be enriched with the addition of CBD. A third product is also being planned by ETST and Bionatus, with details to be shared soon.
The company intends to share further updates on its CBD IP patent formulas as they progress.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Continued progress on CBD patent formulas
- Update on the development of three CBD formulas already under the provisory patent
- Additional three products at various stages with Bionatus
Earth Science Tech, Inc. (OTC: ETST), a biotechnology company focused on cannabidiol (CBD), nutraceuticals, pharmaceuticals and medical devices, shared progress on its CBD patent formulas in a recent press release (http://nnw.fm/O6QyQ). The company has three new CBD formulas under the provisory patent and three Bionatus products in various stages of development.
ETST is developing three CBD formulas already under the provisory patent whose function is to maintain quality of life and prevent inflammation, cancer and degenerative diseases. The company announced in March (http://nnw.fm/QOd0b) that it had received a grant from the Government of Quebec earmarked for the pre-launch process of these three CBD-based nutraceutical provisional patent products.
Research and development has been very promising on the first two unique CBD formula products, a neuron protector and a breast protector. The final formulation is currently being developed to assure the longest possible shelf life using a yet to be determined natural protective agent. The third CBD formula is a unique superfood formulated from a mix of hemp oil and other vegetal oil(s), enriched with potent antioxidants and designed to improve antioxidant ingestion.
ETST has two products in development, Propovit and a reformulation of Bionatus, through a joint venture with Bionatus Laboratrio Botnico of Brazil and its Canadian division, Bionatus Botanical Laboratories, Inc. Propovit is used to help alleviate throat irritation, colds and bad breath. The new formulation will be enriched with ETST hemp oil. The main natural ingredient in Bionatus is the Guaco extract. Traditional uses of this extract suppose anti-inflammatory and bronchial-dilation properties, properties that ETST and Bionatus believe will be enriched with the addition of CBD. A third product is also being planned by ETST and Bionatus, with details to be shared soon.
The company intends to share further updates on its CBD IP patent formulas as they progress.
For more information, visit the company’s website at www.EarthScienceTech.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)Earth Science Tech, Inc. (ETST) Stock Research Links
Scroll down for more posts ▼